Baker Bros. Advisors’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.77M | Sell |
1,712,882
-30,843
| -2% | -$104K | 0.06% | 64 |
|
|
2025
Q1 | $6.73M | Hold |
1,743,725
| – | – | 0.07% | 55 |
|
|
2024
Q4 | $10.8M | Hold |
1,743,725
| – | – | 0.11% | 52 |
|
|
2024
Q3 | $9.38M | Buy |
1,743,725
+48,431
| +3% | +$261K | 0.1% | 54 |
|
|
2024
Q2 | $5.68M | Buy |
1,695,294
+33,174
| +2% | +$111K | 0.07% | 60 |
|
|
2024
Q1 | $6.7M | Buy |
1,662,120
+162,120
| +11% | +$653K | 0.08% | 59 |
|
|
2023
Q4 | $3.98M | Hold |
1,500,000
| – | – | 0.05% | 64 |
|
|
2023
Q3 | $3.54M | Buy |
1,500,000
+1,000,000
| +200% | +$2.36M | 0.02% | 73 |
|
|
2023
Q2 | $3.15M | Sell |
500,000
-126,884
| -20% | -$799K | 0.02% | 86 |
|
|
2023
Q1 | $3.62M | Sell |
626,884
-65,247
| -9% | -$376K | 0.02% | 77 |
|
|
2022
Q4 | $7.1M | Sell |
692,131
-744,505
| -52% | -$7.64M | 0.04% | 69 |
|
|
2022
Q3 | $24M | Hold |
1,436,636
| – | – | 0.16% | 41 |
|
|
2022
Q2 | $20.1M | Hold |
1,436,636
| – | – | 0.11% | 48 |
|
|
2022
Q1 | $23.2M | Hold |
1,436,636
| – | – | 0.13% | 48 |
|
|
2021
Q4 | $30.8M | Hold |
1,436,636
| – | – | 0.15% | 46 |
|
|
2021
Q3 | $21.1M | Hold |
1,436,636
| – | – | 0.09% | 61 |
|
|
2021
Q2 | $28.6M | Hold |
1,436,636
| – | – | 0.13% | 57 |
|
|
2021
Q1 | $43M | Buy |
+1,436,636
| New | +$43M | 0.19% | 43 |
|